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Background: Untreated celiac disease is traditionally believed to be associated with malabsorption and
underweight. However, studies describing body mass index (BMI) in individuals at the time of diagnosis have
shown contradictory results. We investigated the differences in weight, height, and BMI in 12- year-old children
with screening-detected celiac disease compared to their healthy peers.
Methods: In a population-based screening study of 12,632 12-year-old children, blood samples were analyzed
for markers of celiac disease. Children with elevated markers were referred for a small bowel biopsy. Weight and
height were measured in 239 out of 242 children with screening-detected celiac disease (57.3% girls) and in 12,227
children without celiac disease (48.5% girls). BMI was categorized according to the International Obesity Task Force.
Age- and sex-specific cut-off points for underweight, normal weight, and overweight were used.
Results: Children with celiac disease weighed less and were shorter than their peers (median weight 45.2 kg,
interquartile range (IQR) 40.2–52.2 kg vs. 47.0 kg, IQR 41.1–54.4 kg, respectively, p = 0.01; median height 156.5 cm,
IQR 151.0–162.0 cm vs. 157.5 cm, IQR 152.0–163.0 cm, respectively, p = 0.04). In comparing those with celiac
disease to their healthy peers, 4.2% vs. 5.2% were underweight, 82.0% vs. 72.8% were normal weight, and 13.8%
vs. 21.9% were overweight, respectively. There was no association between being underweight and the risk of
having undiagnosed celiac disease (Odds ratio (OR) 1.3, 95% CI 0.7–2.4), but the risk was significantly lower
among overweight children (OR 0.56, 95% CI 0.4–0.8). Median BMI was slightly lower among the children with
screening-detected celiac disease compared to their healthy peers (18.6 kg/m2, IQR 17.1–19.8 kg/m2 vs. 18.8 kg/m2,
IQR 17.2–21.1 kg/m2, respectively, p = 0.05), but most of the celiac disease cases had a normal BMI.
Conclusions: At a population level, children with celiac disease weigh less, are shorter, and have a lower BMI
compared to their peers without celiac disease, and this emphasizes the importance of early recognition and
treatment of the condition. However, at an individual level, growth parameters are not reliable in establishing
the diagnosis.
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Celiac disease is one of the most common chronic dis-
eases in childhood and affects approximately 0.5%–3%
of the population in the Western world [1-3]. It is char-
acterized by an autoimmune response triggered by glu-
ten and other environmental cofactors that leads to
small-intestinal mucosal injury [4]. The disease can have* Correspondence: maria.vanderpals@med.lu.se
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article, unless otherwise stated.its onset at any age throughout life, and its clinical ex-
pression is heterogeneous. The classic presentation of
celiac disease is commonly described as diarrhea, ab-
dominal distention, malnutrition, and failure to thrive
[5-7]. Younger children often present with gastrointes-
tinal symptoms and weight loss, but the clinical presen-
tation seems to have changed in recent decades and the
proportions of patients suffering from classical gastro-
intestinal symptoms, including weight loss, are decreasing.
More patients now suffer from extra-intestinal symptoms
or have no symptoms and are found in screening studiesntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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lished that many adult patients with celiac disease have a
high or normal body mass index (BMI) at diagnosis
[10-13]. Some studies show that BMI increases on a
gluten-free diet, especially in those who adhere closely to
the diet [14]. However, other studies describing BMI in in-
dividuals at diagnosis of celiac disease and/or after intro-
duction of a gluten-free diet have shown contradictory
results. Few studies examining BMI and other growth pa-
rameters have been performed in children, and the find-
ings of those studies have been inconclusive [15-17].
The main objective of this study was to examine
weight, height, and BMI in 12-year-old children with un-
treated screening-detected celiac disease and to compare
these parameters with their healthy peers.
Methods
Study design
The present investigation was based on the children in-
cluded in the ETICS study (Exploring the Iceberg of
Celiacs in Sweden). Details of the celiac disease screen-
ing strategy and descriptions of the included children
have been published previously [3,18]. In brief, ETICS
is a school-based cross-sectional multicenter national
screening study for celiac disease in 12-year-old chil-
dren and is part of the Prevent-CD European project
[19]. Participating families gave their signed informed
consent before the children were enrolled. Children
with an existing diagnosis of celiac disease (n = 96) were
excluded from this study. Blood samples from all children
were analyzed for anti-human tissue transglutaminase
(tTG) and, if borderline values were obtained, also for
endomysial antibodies. Children with values above a
predefined cut-off were referred to the closest pediatric
clinic for a small-intestinal biopsy [20,21]. Criteria for
diagnosis were Marsh 3a-c enteropathy or a combin-
ation of Marsh 1 and Marsh 2 enteropathy, HLA-DQ2/
DQ8 haplotype, and symptoms and/or signs compatible
with celiac disease [21]. Genotyping for HLA alleles encod-
ing for HLA-DQ2/DQ8 was performed by oligonucleotide
probe hybridization and was verified in all screening-
detected cases. The study was approved by the Regional
Ethical Review Board of Umeå University, Umeå, Sweden.
Anthropometric assessment
Weight and height were measured at the time of the
screening for celiac disease according to standard proce-
dures. All school nurses were given uniform instructions
on how to carry out these measurements. The scales
were all recently calibrated, and a wall-mounted stadi-
ometer was used for measuring height. The children
wore light clothing and no shoes and were measured
with their body in a straight line and their head in an ap-
propriate position. BMI was calculated as weight (kg)divided by the square of the height (m2) and categorized
using the cut-off points recommended by the Inter-
national Obesity Task Force (IOTF) [22]. Age- and sex-
specific cut-off points corresponding to the adult BMI
value of <18.5 (defined as underweight) and ≥ 25 (de-
fined as overweight) were used. As a reference, adult
BMI 25 corresponds to 21.22 for 12-year-old boys and
to 21.68 for 12-year-old girls and adult BMI 18.5 corre-
sponds to 15.35 for 12-year-old boys and to 15.62 for
12-year-old girls [22,23].Statistical analysis
Microsoft Access 2010 (Microsoft, Redmond, WA) was
used for handling the ETICS database, and statistical
analysis was performed using SPSS Statistics for Windows
(Version 21.0, IBM Corp, Armonk, NY). Continuous vari-
ables are reported as the median and interquartile range
(IQR) because of unequal sample size and skewed distri-
butions. The 25th and 75th percentiles are described in
the text. Categorical variables are reported as the number
and percentage of subjects with the characteristic of inter-
est. Between-group comparisons were performed with the
Wilcoxon–Mann–Whitney test for continuous variables
and with chi-square or Fisher’s exact test for categorical
variables as appropriate. These tests were performed on
the whole group as well as after stratifications. Univariate
logistic regression models tested the odds of having celiac
disease while being underweight or being overweight. Stat-
istical significance was defined as a two-sided P ≤ 0.05 or
an odds ratio (OR) with a 95% confidence interval (CI)
not including 1.Results
In total, 12,632 children (69% of those invited) partici-
pated. Details regarding the prevalence of celiac disease
have been published previously [3,18]. In total, 242
newly detected celiac disease cases were identified within
the study as a result of the screening. Weight and height
were available in 239 (99%) children with newly detected
celiac disease (57.3% girls) and in 12,227 (99%) of the
study participants without celiac disease (48.5% girls)
(Figure 1).
The children with screening-detected celiac disease
weighed less on average compared to the children with-
out celiac disease (median weight 45.2 kg, IQR 41.1–
54.4 kg vs. 47.0 kg, IQR 40.2–52.2 kg, p = 0.01) (Table 1).
There was no statistically significant difference in weight
between girls and boys within the celiac disease group
(p = 0.86). The children with screening-detected celiac
disease were also significantly shorter compared to the
children without celiac disease (median height 156.5 cm,
IQR 151.0–162.0 cm vs. 157.5 cm, IQR 152.0–163.0 cm,
p = 0.04).
Figure 1 Flowchart depicting the screening procedure. Cross-sectional screenings performed in 12-year-old children across Sweden to
investigate the prevalence of celiac disease (CD) and to assess the growth parameters in comparison with healthy children. The numbers of
children are given in the boxes.
Table 1 Comparison of BMI, weight and height between children without celiac disease (CD) and children with
screening-detected celiac disease
Groups, n (%) No CD n = 12,227 CD n = 239 P-valuea
Girls, n (%) 5932 (48.5) 137 (57.3)
Age-and sex-adjusted BMI, n (%)
<18.5 kg/m2 641 (5.2) 10 (4.2)
18.5-24.9 kg/m2 8906 (72.8) 196 (82.0)
≥25 kg/m2 2680 (21.9) 33 (13.8) 0.01*
BMI (kg/m2) median (IQR)
All 18.8 (3.85) 18.6 (3.15) 0.05*
Girls 18.8 (3.84) 18.6 (3.37) 0.22
Boys 18.8 (3.88) 18.6 (2.67) 0.13
Weight (kg) median (IQR)
All 47.0 (13.3) 45.2 (12.0) 0.01*
Girls 47.1 (12.9) 44.9 (13.0) 0.07
Boys 47.0 (13.6) 46.2 (11.0) 0.09
Height (cm) median (IQR)
All 157.5 (11.0) 156.5 (11.0) 0.04*
Girls 158.0 (9.9) 156.0 (10.4) 0.04*
Boys 157.0 (11.2) 157.0 (12.6) 0.32
aStatistical significance defined as P ≤ 0.05 and marked with *.
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overweight differed significantly between the groups.
Among the patients with screening-detected celiac disease,
4.2% were underweight, 82.0% were of normal weight, and
13.8% were overweight. In the group of healthy children,
the proportions were 5.2%, 72.8% and 21.9%, respectively
(Table 1). Using children with normal weight as a reference
group, there was no association between being under-
weight and the risk of having undiagnosed celiac disease
(OR 1.3, 95% CI 0.7–2.4). However, the risk of having ce-
liac disease was significantly lower among overweight chil-
dren (OR 0.56, 95% CI 0.4–0.8).
BMI was slightly lower among the children with
screening-detected celiac disease compared to their
healthy peers (median 18.6 kg/m2, IQR 17.1–19.8 kg/m2
vs. 18.8 kg/m2, IQR 17.2–21.1 kg/m2, p = 0.05).
Among the girls with screening-detected celiac disease
(n = 137), 2.2% were underweight, 83.9% were of normal
weight, and 13.9% were overweight compared to 6.6%,
73.8%, and 19.8% of their healthy peers, respectively
(p = 0.02). The girls with screening-detected celiac disease
were also significantly shorter compared to their healthy
peers (median height 156.0 cm, IQR 151.6–162.0 cm vs.
158.0 cm, IQR 153.0–162.9 cm, p = 0.039). Among the
boys with screening-detected celiac disease (n = 102), 6.9%
were underweight, 79.4% were of normal weight, and
13.7% were overweight compared to 4.0%, 72.0%, and
24.1%, respectively, among their healthy peers (p = 0.03).
Over all, the distribution of underweight, normal weight,
and overweight in sex-stratified subgroups showed a simi-
lar pattern as the whole group (Table 2).
Discussion
In this large population-based celiac disease screening
study, we found that children with untreated celiac dis-
ease were moderately shorter, weighed less, and had aTable 2 Comparison of BMI between girls and boys
without celiac disease (CD) and girls and boys with
screening-detected celiac disease
Groups, n (%) No CD CD P-valuea
Girls 5932 (48.5) 137 (57.3)
Age- and sex-adjusted BMI
<18.5 kg/m2 391 (6.6) 3 (2.2)
18.5-24.9 kg/m2 4376 (73.8) 115 (83.9)
≥25 kg/m2 1165 (19.6) 19 (13.9) 0.02*
Boys 6295 (51.5) 102 (42.7)
Age- and sex-adjusted BMI
<18.5 kg/m2 250 (4.0) 7 (6.9)
18.5-24.9 kg/m2 4530 (72.0) 81 (79.4)
≥25 kg/m2 1515 (24.0) 14 (13.7) 0.03*
aStatistical significance defined as P ≤ 0.05 and marked with *.slightly lower BMI compared to their healthy peers. Even
though having undiagnosed celiac disease was not associ-
ated with being underweight, only a few were overweight
and the majority of the children with screening-detected
celiac disease had a normal weight.
In 2004, an American study found that children with
tTG-positive screening-identified celiac disease weighed
less compared to healthy children and other recent stud-
ies have found that children with celiac disease are less
frequently overweight or obese and more often under-
weight than controls [15,17]. Some studies in patients
with celiac disease have also found other factors associ-
ated with low BMI such as the extent of mucosal injury,
presentation with diarrhea and female sex [12]. Studies
performed in adults have shown similar results as in this
study with regard to BMI [10,24].
Even if celiac disease is classically associated with mal-
absorption and weight loss, one must bear in mind that
children with undiagnosed celiac disease can have differ-
ent body compositions. The fact that the proportion of
underweight children with celiac disease in our study
was only 4.2% emphasizes that celiac disease should not
be considered primarily as a malabsorption disorder. In
addition, although celiac disease was found in this study
to be distinctly less common among overweight chil-
dren, being overweight does not necessarily rule out ce-
liac disease.
In some studies, overweight has been found to be
more common in boys with celiac disease than in girls
[12,25]. In contrast, the same weight pattern was found
to apply to both boys and girls and no indications of any
gender differences in the proportion of overweight within
the celiac disease group were found in the present study.
In the current study, girls with celiac disease were signifi-
cantly shorter than their healthy peers. This is consistent
with other studies, including one study conducted in
Finland that found that the screening-detected adolescent
celiac disease subjects were not only shorter but one third
also had nutritional abnormalities [16,26]. Even more ex-
tensive nutritional deficiencies were found in a recently
conducted Dutch study in which 7.5% of the individuals
with celiac disease were found to be underweight but the
nutritional deficiencies were present even in obese pa-
tients [27]. This is important to keep in mind when con-
sidering the need for more active screening for the
disease in order to prevent the progression of nutri-
tional deficiencies.
The results regarding height are more inconsistent
than those for weight. In some studies, adult men with
celiac disease have been found to be shorter [24,28], but
another study indicated that the mean adult height of
patients with celiac disease was the same as that of the
general population. In a subgroup analysis, reduced
height was observed in the older, but not younger, birth
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found that celiac disease diagnosed in childhood results
in catch-up growth once a gluten-free diet is introduced,
but still others found that men and women with celiac
disease were shorter compared to controls [30-32]. Part
of the differences found regarding height in the above-
mentioned studies might be explained by differences in
the investigated age span in the study populations. In
the present study, it is likely that a majority of the girls
at 12 years of age have reached the onset of puberty and
that they are in the middle of their growth spurt. The on-
set of puberty corresponds to a biological (i.e., skeletal)
age of approximately 11 years in girls and 13 years in boys.
The timing of the pubertal growth spurt occurs earlier in
girls and tends not to reach the same magnitude as that of
boys. Girls average a peak growth velocity of 9 cm/year at
age 12 and a total gain in height of 25 cm during the pu-
bertal growth period. Boys attain an average peak growth
velocity of 10.3 cm/year – which occurs about 2 years
later than in girls – and gain 28 cm in height during the
pubertal growth period [33-35]. This means that the ma-
jority of the girls participating in this study were in the
middle of their peak height velocity when the study took
place. It is possible, therefore, that untreated celiac disease
gives them worse preconditions for the growth spurt or
that the disease influences the onset of puberty and results
in a delay in peak growth velocity. Additional epidemio-
logic research is needed to confirm these results, and
more research needs to be done to understand the patho-
genesis of short stature in patients with celiac disease.
The present investigation was based on a nationwide,
contemporary study on celiac disease in 12,632 children.
The screening-detected cases were ascertained by small-
intestinal biopsies and HLA-DQ testing. However, the
study has some limitations that merit consideration.
First, the growth parameters, and thus the BMI, of the
children were available only at the time of the screening.
Repeated weight and height measurements following the
initiation of a gluten-free diet would permit an evalu-
ation of the effect of the diet on the nutritional status of
the children. Although this is an important question that
warrants further research, it is beyond the scope of this
study. Furthermore, evaluating growth parameters at the
time of the screening without the children knowing their
diagnosis provides only a snapshot of the nutritional
status in these children with untreated celiac disease
compared to their healthy peers. Second, although the
screening study included 12,632 children, statistical
power might still constitute a limitation of the current
study. There were only 239 children with celiac disease
in this cohort, and only 102 were boys. The relatively
low number of children with celiac disease might explain
why no statistically significant differences in anthropomet-
ric measurements were found in this subgroup. However,at a population level, the growth parameters tended to be
affected in the same way in boys as in girls and in the ce-
liac disease cohort as a whole.
Overall, this study still has several strengths. To the
best of our knowledge, it is the first large cross-sectional
study where all the children enrolled were of the same
age. The weight and height measurements were also per-
formed according to standard procedures (as opposed to
self-reported), and this makes them very reliable and
comparable. Also, the celiac disease diagnosis was estab-
lished using state of the art techniques including sero-
logic markers and small-intestinal biopsies.
Conclusions
The majority of the children with screening-detected ce-
liac disease were of normal weight and there was no as-
sociation between being underweight and the risk of
having undiagnosed celiac disease. At a population level,
the 12-year-old children with screening-detected celiac
disease weighed less and were shorter compared to their
peers without celiac disease, and this indicates a need to
detect and treat celiac disease. However, at the individual
level growth parameters are not reliable in predicting ce-
liac disease. Although celiac disease is less common in
the overweight subgroup, being overweight does not ne-
cessarily rule out celiac disease.
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